Cannabinoids and inflammation

Reading this collection

Inflammation is a mechanism rather than a diagnosis, so the research collected here cuts across several presentations — joint pain, bowel inflammation, and systemic inflammatory markers among them. That breadth is worth keeping in mind when reading any single study: an endpoint measured in innate immune cells is not the same claim as an endpoint measured in patients.

The records below are grouped by their reported indication, not by strength of conclusion. Evidence tier is shown against each so the distinction between a mechanistic source and a human clinical endpoint stays visible.

The evidence in this library

10 source-linked studies — 9 scientific source · 1 human clinical evidence. Each links to its source; identifiers are shown where the record carries them.

1. Cannabidiol acts as molecular switch in innate immune cells to promote inflammation-resolving lipid mediators

   2023 · PubMed / PMC · CBD

   Human clinical evidence

   PMID 37647900 · PMCID PMC12233155 · DOI 10.1016/j.chembiol.2023.08.001

2. Medical Cannabis Activity Against Inflammation: Active Compounds and Mechanisms

   2022 · PMC / NCBI · CBD, THC, Full Spectrum

   Scientific source

   PMID 35614947 · PMCID PMC9124761

3. Antioxidative and Anti-inflammatory Properties of Cannabidiol

   2020 · PMC / NCBI · CBD

   Scientific source

   PMID 31881765 · PMCID PMC7023045 · DOI 10.3390/antiox9010021

4. Beta-Caryophyllene CB2 agonist for inflammation

   NCBI

   Scientific source

   PMID 18574142

5. Formulation evidence: Cannoflam — MCT Oil (Carrier)

   PubMed · Caprylic acid (C8), Capric acid (C10)

   Scientific source

   PMID 29580532

6. THCA shows potent anti-inflammatory effects

   NCBI

   Scientific source

   PMID 24097268

7. CBD research source — pmc.ncbi.nlm.nih.gov

   PMC / NCBI · CBD

   Scientific source

   PMID 32231748 · PMCID PMC7092763

8. CBD research source — pmc.ncbi.nlm.nih.gov

   PMC / NCBI · CBD

   Scientific source

   PMID 30374683 · PMCID PMC6223703

9. CBD research source — pmc.ncbi.nlm.nih.gov

   PMC / NCBI · CBD

   Scientific source

   PMID 32159404 · PMCID PMC8262682

10. CBDA more potent than CBD: COX-2 inhibition

    NCBI

    Scientific source

    PMID 23298862

How to read this evidence

These are the boundaries recorded against the studies above, reproduced as written in the library:

• Mechanistic/symptom-support rationale only; avoid disease-cure or product-specific proof unless clinical endpoint exists.
• Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.